Skip to content

Stryker SYK United States — Net Sales

Other financials

Income statement

See full
Revenue$6.0B+2.6%
Gross profit$3.8B+1.8%
Operating income$936.0M+11.8%
Net income$745.0M+13.9%
EPS (diluted)$1.93+14.2%

Balance sheet

See full
Cash & equivalents$2.9B+24.1%
Total debt$14.4B-15.1%
Total assets$46.3B+0.6%

Cash flow

See full
Operating cash flow$581.0M+132%
CapEx$166.0M+35.0%
Free cash flow$415.0M+227%

Valuation

See full
Market cap$125.4B-16.4%
Enterprise value$136.91B-16.7%
P/E37.6×-13.8×
P/S-1.3×

Profitability

See full
Gross margin63.8%-0.1pp
Operating margin19.7%+4.4pp
Net margin13.2%+0.9pp
FCF margin18.1%+2.7pp

Returns & leverage

See full
Return on equity32.8%
Debt / equity0.8×
Current ratio2.1×+0.5×

Where this comes from

Reported directly by Stryker in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Stryker’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stryker's united states — net sales.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stryker's united states — net sales?
Stryker (SYK) reported united states — net sales of $4.48B in Q1 2026.
How has Stryker's united states — net sales changed year-over-year?
Stryker's united states — net sales increased by 0.8% year-over-year, from $4.44B to $4.48B.
What is the long-term trend for Stryker's united states — net sales?
Over 4 years (2021 to 2025), Stryker's united states — net sales has grown at a 11.4% compound annual growth rate (CAGR), from $12.32B to $19.01B.